Loading...
Harvard Bioscience, Inc.
HBIO•NASDAQ
Healthcare
Medical - Instruments & Supplies
$0.56
$-0.01(-0.93%)
Harvard Bioscience, Inc. (HBIO) AI-Powered Stock Analysis
See how Harvard Bioscience, Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerHarvard Bioscience, Inc. (HBIO) Stock Overall Grade
Harvard Bioscience, Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Harvard Bioscience, Inc.'s overall stock rating.
Forecast
C+Score
54/100Financial Growth
C+Score
50/100Fundamental Growth
C+Score
57/100Key Ratios
BScore
60/100Sector Comparison
B+Score
75/100Industry Comparison
B+Score
75/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
C+Score
50/100Harvard Bioscience, Inc. (HBIO) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 54/100 (C+), reflecting weak confidence in its potential. Financial Growth (50/100, C+) and Fundamental Growth (57/100, C+) highlight its stability, while Key Ratios (60/100, B) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (85/100, A), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Harvard Bioscience, Inc. stock grade, including financials, comparisons, and forecasts.